Eurobio Scientific S.A.
ALERS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €81,200 | €81,626 | €73,453 | €71,274 |
| % Growth | -0.5% | 11.1% | 3.1% | – |
| Cost of Goods Sold | €43,000 | €45,099 | €40,103 | €40,605 |
| Gross Profit | €38,200 | €36,527 | €33,350 | €30,669 |
| % Margin | 47% | 44.7% | 45.4% | 43% |
| R&D Expenses | €2,100 | €1,883 | €4,226 | €2,811 |
| G&A Expenses | €7,700 | €7,630 | €7,550 | €8,878 |
| SG&A Expenses | €25,800 | €26,007 | €19,493 | €20,327 |
| Sales & Mktg Exp. | €18,100 | €11,735 | €11,943 | €11,449 |
| Other Operating Expenses | €4,500 | €4,210 | €2,802 | €4,605 |
| Operating Expenses | €32,400 | €32,100 | €26,521 | €27,743 |
| Operating Income | €5,800 | €8,637 | €6,829 | €6,072 |
| % Margin | 7.1% | 10.6% | 9.3% | 8.5% |
| Other Income/Exp. Net | -€2,000 | -€8,228 | -€938 | -€1,998 |
| Pre-Tax Income | €3,800 | €393 | €5,891 | €4,074 |
| Tax Expense | €1,400 | €408 | €1,892 | €1,430 |
| Net Income | €2,400 | €1 | €3,999 | €2,644 |
| % Margin | 3% | 0% | 5.4% | 3.7% |
| EPS | 0.23 | 0 | 0.4 | 0.29 |
| % Growth | 229,900% | -100% | 37.9% | – |
| EPS Diluted | 0.23 | 0 | 0.4 | 0.22 |
| Weighted Avg Shares Out | 10,249 | 10,249 | 10,027 | 9,165 |
| Weighted Avg Shares Out Dil | 10,249 | 10,249 | 10,027 | 10,713 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €838 | €638 | -€624 |
| Interest Expense | €2,100 | €2,561 | €2,153 | €2,161 |
| Depreciation & Amortization | €4,757 | €1,920 | €4,664 | €7,585 |
| EBITDA | €10,557 | €8,185 | €11,492 | €13,820 |
| % Margin | 13% | 10% | 15.6% | 19.4% |